Developing a genomic test for early stage breast cancer.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/17/2022 |
Offer Price | |
Price Range $7.44 - $7.44 | |
Offer Shares (mm) | 1.5 |
Deal Size ($mm) | $11 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range $7.44 - $7.44 | |
Offer Shares (mm) | 1.5 |
Deal Size ($mm) | $11 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
ThinkEquity |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2020 |
Employees at IPO | 4 |
Website www.AccuStem.com |